A new European leader in the orthopedic sector, Mediliant, a Swiss orthopedic contract manufacturer, advised by Potomac, makes its second acquisition in the US with Culver Tool & Engineering, the world leader in manufacturing “Rods”
«Many thanks to Potomac for this acquisition! Pleasure and efficiency in working with you. We form a very good team with you, Mediliant and Ekkio. We could not have done this without you.
Thanks again and … see you soon!»
Jean-Marc Sceo, President of Ekkio Capital
Based in Switzerland, in the heart of a dynamic medical industry, Mediliant, orthopedic contract manufacturer is spine-off of a Zimmer Biomet entity. Quickly Mediliant established itself with a full-service manufacturing offer to customers for extremity and trauma implants.
With the support of d’Ekkio Capital, main shareholder since 2019, Mediliant Group realized the acquisition of Culver Tool & Engineering (“CTE”), the second in the US in less than 6 months after the acquisition of Medical Device & Implant in August 2020. During the last 18 months, Mediliant Group has developed its revenues from $10 million to $60 million to join the top 10 worldwide orthopedic CMO in the dynamic “SET” Spine, Extremity & Trauma implant segment.
Financial advisor since the first transaction in 2019, Potomac Transactions advised Mediliant and Ekkio Capital on their 3rd transaction, the acquisition and the financing of CTE in the US. Based in Plymouth, area of Warsaw Indiana, the world capital of orthopedic, CTE is the world leader in manufacturing Rods for spine surgeries.